These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15865215)

  • 1. The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function.
    Piccinini M; Rinaudo MT; Anselmino A; Buccinnà B; Ramondetti C; Dematteis A; Ricotti E; Palmisano L; Mostert M; Tovo PA
    Antivir Ther; 2005; 10(2):215-23. PubMed ID: 15865215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.
    Pajonk F; Himmelsbach J; Riess K; Sommer A; McBride WH
    Cancer Res; 2002 Sep; 62(18):5230-5. PubMed ID: 12234989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors.
    Jones SP; Janneh O; Back DJ; Pirmohamed M
    Antivir Ther; 2005; 10(2):207-13. PubMed ID: 15865214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations.
    Kraus M; Müller-Ide H; Rückrich T; Bader J; Overkleeft H; Driessen C
    Leuk Res; 2014 Mar; 38(3):383-92. PubMed ID: 24418752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular disposition and metabolic effects of zidovudine, stavudine and four protease inhibitors in cultured adipocytes.
    Janneh O; Hoggard PG; Tjia JF; Jones SP; Khoo SH; Maher B; Back DJ; Pirmohamed M
    Antivir Ther; 2003 Oct; 8(5):417-26. PubMed ID: 14640389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APHS can act synergically with clinically available HIV-1 reverse transcriptase and protease inhibitors and is active against several drug-resistant HIV-1 strains in vitro.
    Pereira CF; Paridaen JT; van de Bovenkamp M; Middel J; Verhoef J; Nottet HS
    J Antimicrob Chemother; 2003 May; 51(5):1181-9. PubMed ID: 12668583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of TNF-alpha mediated cell death by HIV-1 specific protease inhibitors.
    Wolf T; Findhammer S; Nolte B; Helm EB; Brodt HR
    Eur J Med Res; 2003 Jan; 8(1):17-24. PubMed ID: 12578750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells.
    Hamel FG; Fawcett J; Tsui BT; Bennett RG; Duckworth WC
    Diabetes Obes Metab; 2006 Nov; 8(6):661-8. PubMed ID: 17026490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human 26S proteasome is a target of antiretroviral agents.
    Piccinini M; Rinaudo MT; Chiapello N; Ricotti E; Baldovino S; Mostert M; Tovo PA
    AIDS; 2002 Mar; 16(5):693-700. PubMed ID: 11964525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress.
    Pyrko P; Kardosh A; Wang W; Xiong W; Schönthal AH; Chen TC
    Cancer Res; 2007 Nov; 67(22):10920-8. PubMed ID: 18006837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of human immunodeficiency virus protease inhibitors against Pneumocystis carinii.
    Atzori C; Angeli E; Mainini A; Agostoni F; Micheli V; Cargnel A
    J Infect Dis; 2000 May; 181(5):1629-34. PubMed ID: 10823762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HIV protease inhibitors saquinavir, ritonavir, and nelfinavir induce apoptosis and decrease barrier function in human intestinal epithelial cells.
    Bode H; Lenzner L; Kraemer OH; Kroesen AJ; Bendfeldt K; Schulzke JD; Fromm M; Stoltenburg-Didinger G; Zeitz M; Ullrich R
    Antivir Ther; 2005; 10(5):645-55. PubMed ID: 16152758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
    Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J
    Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.
    Gaucher B; Rouquayrol M; Roche D; Greiner J; Aubertin AM; Vierling P
    Org Biomol Chem; 2004 Feb; 2(3):345-57. PubMed ID: 14747863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein.
    Storch CH; Theile D; Lindenmaier H; Haefeli WE; Weiss J
    Biochem Pharmacol; 2007 May; 73(10):1573-81. PubMed ID: 17328866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro.
    Hampson L; Kitchener HC; Hampson IN
    Antivir Ther; 2006; 11(6):813-25. PubMed ID: 17310826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quadruple-2 protease inhibitors (PI)-therapy does not accelerate viral decay and suppression in PI-naive HIV-1 infected patients with severe immunosuppression and high viral load as compared with standard triple therapy.
    Portilla J; Boix V; Garcia-Henarejos JA; Llopis C; Martínez-Madrid O; Gimeno A; Sánchez-Paya J; Merino E
    Int J STD AIDS; 2005 Dec; 16(12):807-10. PubMed ID: 16336763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory aspartyl peptidase activity from mycelia of the human fungal pathogen Fonsecaea pedrosoi: effect of HIV aspartyl proteolytic inhibitors.
    Palmeira VF; Kneipp LF; Alviano CS; dos Santos AL
    Res Microbiol; 2006 Nov; 157(9):819-26. PubMed ID: 16959473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors.
    Trudel N; Garg R; Messier N; Sundar S; Ouellette M; Tremblay MJ
    J Infect Dis; 2008 Nov; 198(9):1292-9. PubMed ID: 18816190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic inhibition of protease-inhibitor-resistant HIV type 1 by saquinavir in combination with atazanavir or lopinavir.
    Dam E; Lebel-Binay S; Rochas S; Thibaut L; Faudon JL; Thomas CM; Essioux L; Hill A; Schutz M; Clavel F
    Antivir Ther; 2007; 12(3):371-80. PubMed ID: 17591027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.